Gram Positive (Carreno) Flashcards
Penicillin Coverage
Strep pneumo
E. coli
PSSA
NO MOD/HIGH COVERAGE
Penicillin Distribution
WIDELY DISTRIBUTED
3rd Gen Cephalosporins (6)
aka “3rd Gen Ceph”
Cefdinir Cefixime Cefoperazone Ceftaxime Ceftazidime Ceftriaxone
MOA: prevent transpeptidation reaction
3rd Gen Ceph Coverage
G+: Strep pneumo, MSSA
G-: E.coli, Kleb pneumo
NO HIGH COVERAGE
3rd Gen Ceph Distribution (4)
CNS (good)
Intra-abdomen
Urine
Skin
Type 1 beta-lactam allergy
+
Conditions
Immediate
IgE-mediated
Anahpylaxis within minutes
Type 2 beta-lactam allergy
+
Conditions
Production of cytotoxic Abs
IgG + IgM mediated
Thrombocytopenia, nephritis, dose/duration dependent
Type 3 beta-lactam allergy
+
Conditions
IMMUNE COMPLEX MEDIATED
Formation of immune complexes
IgG + IgM
Serum sickness within 7-14d
Type 4 beta-lactam allergy
+
Conditions
CELL MEDIATED (NO ABs) T-cell dependent
Inflammation + contact dermatitis
Macrolides
Eryhtromycin
Clarithromycin
Azithromycin
MOA: bind 50S subunit, prevent peptide bond formation
Macrolide Coverage
S.pneumo \+ H.influenza M. catarrhalis Mycoplasma Chlamydia Leginoella
Macrolide Distribution
Upper Resp
Lower Resp
Tissues (i.e. cervix, ovaries, prostate)
Key Clinical Uses:
Erythromycin
Strep pneumo
Promotility agent
Key Clinical Uses:
Clarithromycin
Community Acquired Pneumonia (CAP)
Mycobacterium Avium Intracellularae (MAI)
H.pylori
Key Clinical Uses:
Azithromycin
URTI (upper respiratory infections) CAP MAI Cystic Fibrosis COPD exacerbations Chlamydial infections Gonorrhea (@ high doses)
Macrolide: ADEs
Diarrhea
Vomiting
QT-prolongation
CYP3A4 interactions (E > C > A) i.e. STATINS
Fluoroquinolones
MOA: Toposiomerase/gyrase inhibition
ATYPICAL BACTERIA
Moxifloxacin (G+)
Levofloxacin (broad/both)
Ciprofloxacin (G-)
Coverage: Moxifloxacin
G+
Strep pneumo
E.coli, Kleb pneumo, G- anaerobes
Coverage: Levofloxacin
BROAD (both)
Strep pneumo
Ecoli, Kleb pneumo, PSAR
Coverage: Ciprofloxacin
G-
NO G+ activity
E.coli, Kleb pneumo, PSAR
Fluoroquinolone Absorption/Bioavailability
Moxi + Levo –> 100%
Cipro –> 80%
Fluoroquinolone Distribution
Lungs: Moxi + Levo
Urine: Levo + Cipro
Intra-abdomen: Moxi, Levo, Cipro
Fluoroquinolone Excretion
Renal: Levo + Cipro
Hepatic: Moxi
Major Fluoroquinolone ADE
QT Prolongation Tendinitis + Tendon Rupture Hypersensitivity N/V Diarrhea Dizziness Headaches Insomnia
ABCs of Staph aureus
A --> absence of resistance elements B --> beta-lactamase presence C --> changes in PBP D --> d-ALA-d-ALA alterations (VRSAs) E --> extra-thick walls
Penicillinase-Resistant Penicillins (2) + Dosing
Oxacillin Nafcillin 2g IV q4h (SAME FOR BOTH) NO ADJUSTMENT FOR RENAL -monitor liver enzymes + interstitial nephritis
Penicillinase-Resistant Penicillins: Coverage
NO G- ACTIVITY
Strep pneumo, MSSA
Penicillinase-Resistant Penicillins: Distribution
Blood
Skin
Urine (?)
1st Gen Cephs (4)
Cefazolin (PO)
Cephalexin (IV)
Cephadroxil (PO)
Cephalothin (IV)
1st Gen Cephs: Coverage
Strep pneumo, MSSA
E.coli
1st Gen Ceph: Distribution
Skin
Urine
(POOR CNS)
Beta-lactam + beta-lactamase inhibitor (3)
Amoxacillin/Clavulanate
Ampicillin/Sulbactam
Pipercillin/Tazobactam
Coverage: Amox/Clav + Amp/Sulbactam
Strep pneumo, MSSA
E.coli
**sulbactam selectively toxic vs. acinetobacter
Coverage: Piper/Tazo
Strep pneumo, MSSA
E.coli, Kleb pneumo, PSAR
**additional G- anaerobe coverage
Coverage: Vancomycin
Strep pneumo, MSSA, MRSA, E.faecalis
**NO G-
IV –> MRSA and PO –> C.diff
Distribution: Vancomycin
Low PO Bioavailability
Blood
Urine
Lung, bone, CNS, heart (?)
Distribution: Daptomycin
Skin
Heart
(Inactivated in lungs)
Coverage: Daptomycin
Strep pneumo, MSSA/MRSA, E.faecalis
**NO G-
Daptomycin ADEs
Skeletal muscle toxicity
Concurrent use of statin
Eosinophili pneumonia (rare)
Telavancin: Type + ADEs
Lipogylcopeptide
QTc prolongation + red-man syndrome
2x potential nephrotoxicity as vancomycin
Linezolid: Coverage
Strep pneumo, MSSA/MRSA, E.faecalis
**NO G-
Linezolid: Distribution
Low serum concentrations
EXCELLENT for lungs
Skin
Urine
Linezolid: Info and ADEs
100% Bioavailability
No renal dose adjustment
Serotonin response syndrome
Peripheral/otic neuropathy
Thrombocytopenia/anemia
Tigecycline: Coverage
Strep pneumo, MSSA/MRSA, E.faecalis
E.coli, Kleb pneumo
+ H.influenza, M.catarrahlis, Acinetobacter
Tigecycline: Distribution
Intra-abdomen
Skin
Lungs (?)
VERY LOW SERUM/URINE concentrations
**adjust for hepatic dysfunction
Tigecycline: ADEs
N/V
Ceftaroline: Coverage
Strep pneumo, MSSA/MRSA
E.coli, Kleb pnemo
Ceftaroline: Distribution
Lungs
Skin
Other (?)
**adjust for CrCl < 50mL/min